Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy

International Journal of Gynecological Cancer

Volumn 12, Issue 3, 2002, Pages 250-256

  Fujiwara, K ^a   Suzuki, S ^a   Yoden, E ^a   Ishikawa, H ^a   Imajo, Y ^a   Kohno, I ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Chemoresistant; Focal radiation therapy; Ovarian cancer; Palliation; Symptoms

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; IRINOTECAN; MITOMYCIN C; PACLITAXEL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SIZE; CLINICAL ARTICLE; ENTEROPATHY; FEMALE; HUMAN; LYMPH NODE; OVARY CANCER; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; SYMPTOMATOLOGY;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CARCINOMA, ENDOMETRIOID; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036074798     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01096.x     Document Type: Article

References (16)

1. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
2. Update on the role of radiotherapy in ovarian cancer
3. Palliative benefit of radiation therapy in advanced ovarian cancer
4. The efficacy of cranial irradiation in ovarian cancer metastatic to the brain: Analysis of 32 cases
5. Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma
6. New guidelines to evaluate the response to treatment in solid tumors
7. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer
8. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma
9. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
10. Whole abdomen radiation as a second-line therapy for epithelial ovarian cancer
11. A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked Stage I, II, and III ovarian cancer
12. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy
13. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
14. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer
15. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
16. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study